ADMA logo

ADMA Biologics (ADMA) EBIT

Annual EBIT

-$3.21 M
+$43.41 M+93.11%

31 December 2023

3-Year Change

+94.52%
ADMA annual earnings before interest & taxes is up +94.52% over the past 3 years

All-time High

$5.12 M
ADMA annual earnings before interest & taxes is currently -162.73% below its historical high of $5.12 million

Sector Rank

78.74%
ADMA annual earnings before interest & taxes is higher than 78.74% of companies in Healthcare sector

Annual EBIT Formula

Revenue − COGS − Operating Expenses
Annual Revenue$258.21 M
ADMA annual revenue is $258.21 million
Annual Gross Profit$88.94 M
ADMA annual gross profit is $88.94 million
Annual Net Income-$28.24 M
ADMA annual net profit is -$28.24 million

ADMA EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

$40.25 M
+$614.00 K+1.55%

30 September 2024

1-Year Change

+452.13%
ADMA quarterly earnings before interest & taxes is up +452.13% year-on-year

3-Year Change

+401.85%
ADMA quarterly earnings before interest & taxes is up +401.85% over the past 3 years

All-time High

$40.25 M
ADMA quarterly earnings before interest & taxes is currently at an all-time high

Sector Rank

88.41%
ADMA quarterly earnings before interest & taxes is higher than 88.41% of companies in Healthcare sector
Quarterly Gross Profit$59.66 M
ADMA quarterly gross profit is $59.66 million
Quarterly Operating Expenses$20.02 M
ADMA quarterly total operating expenses is $20.02 million
Quarterly Revenue$119.84 M
ADMA quarterly revenue is $119.84 million
Quarterly Net Income$35.91 M
ADMA quarterly net profit is $35.91 million

ADMA Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

$90.62 M
+$31.29 M+52.72%

30 September 2024

1-Year Change

+2920.48%
ADMA TTM earnings before interest & taxes is up +2920.48% year-on-year

3-Year Change

+254.67%
ADMA TTM earnings before interest & taxes is up +254.67% over the past 3 years

All-time High

$90.62 M
ADMA TTM earnings before interest & taxes is currently at an all-time high

Sector Rank

87.37%
ADMA TTM earnings before interest & taxes is higher than 87.37% of companies in Healthcare sector
TTM Revenue$382.81 M
ADMA TTM revenue is $382.81 million
TTM Gross Profit$187.31 M
ADMA TTM gross profit is $187.31 million
Annual Operating Expenses$67.31 M
ADMA annual total operating expenses is $67.31 million
TTM Net Income$68.13 M
ADMA TTM net profit is $68.13 million

ADMA TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+452.1%+2920.5%
3 y3 years+94.5%+401.9%+254.7%
5 y5 years+91.8%+614.0%+330.7%

ADMA EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+94.5%at high+286.2%at high+239.4%
5 y5 yearsat high+95.0%at high+286.2%at high+239.4%
alltimeall time<-9999.0%+95.0%at high+286.2%at high+239.4%

ADMA Biologics EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
$40.25 M(+1.5%)
$90.62 M(+52.7%)
June 2024
-
$39.63 M(+78.8%)
$59.34 M(+202.3%)
Mar 2024
-
$22.17 M(-294.0%)
$19.63 M(-711.0%)
Dec 2023
-$3.21 M(-93.1%)
-$11.43 M(-227.5%)
-$3.21 M(-286.6%)
Sept 2023
-
$8.96 M(<-9900.0%)
$1.72 M(-110.4%)
June 2023
-
-$72.00 K(-89.3%)
-$16.56 M(-35.5%)
Mar 2023
-
-$674.00 K(-89.6%)
-$25.68 M(-44.9%)
Dec 2022
-$46.63 M(-20.4%)
-$6.50 M(-30.3%)
-$46.63 M(-12.8%)
Sept 2022
-
-$9.32 M(+1.4%)
-$53.46 M(-8.7%)
June 2022
-
-$9.19 M(-57.5%)
-$58.56 M(-9.9%)
Mar 2022
-
-$21.62 M(+62.1%)
-$65.03 M(+11.0%)
Dec 2021
-$58.59 M(-8.1%)
-$13.33 M(-7.5%)
-$58.59 M(-4.8%)
Sept 2021
-
-$14.41 M(-7.9%)
-$61.56 M(+1.0%)
June 2021
-
-$15.66 M(+3.1%)
-$60.97 M(-2.3%)
Mar 2021
-
-$15.18 M(-6.8%)
-$62.42 M(-2.1%)
Dec 2020
-$63.76 M(+62.3%)
-$16.30 M(+17.9%)
-$63.76 M(+15.3%)
Sept 2020
-
-$13.83 M(-19.2%)
-$55.30 M(+10.0%)
June 2020
-
-$17.11 M(+3.5%)
-$50.26 M(+13.5%)
Mar 2020
-
-$16.53 M(+111.1%)
-$44.29 M(+12.7%)
Dec 2019
-$39.29 M(-34.8%)
-$7.83 M(-10.9%)
-$39.29 M(-18.2%)
Sept 2019
-
-$8.79 M(-21.1%)
-$48.06 M(-9.3%)
June 2019
-
-$11.14 M(-3.4%)
-$53.00 M(-4.1%)
Mar 2019
-
-$11.53 M(-30.6%)
-$55.25 M(-8.3%)
Dec 2018
-$60.22 M(+48.8%)
-$16.60 M(+20.9%)
-$60.22 M(+8.8%)
Sept 2018
-
-$13.73 M(+2.6%)
-$55.36 M(-1.2%)
June 2018
-
-$13.39 M(-18.9%)
-$56.05 M(+9.8%)
Mar 2018
-
-$16.50 M(+40.5%)
-$51.05 M(+26.1%)
Dec 2017
-$40.47 M
-$11.74 M(-18.6%)
-$40.47 M(+23.9%)
Sept 2017
-
-$14.42 M(+71.8%)
-$32.66 M(+48.7%)
June 2017
-
-$8.39 M(+41.8%)
-$21.97 M(+15.3%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$5.92 M(+50.6%)
-$19.05 M(+10.3%)
Dec 2016
-$17.28 M(+7.1%)
-$3.93 M(+5.5%)
-$17.28 M(-1.1%)
Sept 2016
-
-$3.73 M(-31.9%)
-$17.46 M(-5.0%)
June 2016
-
-$5.47 M(+32.1%)
-$18.39 M(+7.3%)
Mar 2016
-
-$4.14 M(+0.6%)
-$17.14 M(+6.3%)
Dec 2015
-$16.13 M(+0.3%)
-$4.12 M(-11.5%)
-$16.13 M(+2.4%)
Sept 2015
-
-$4.65 M(+10.1%)
-$15.74 M(+11.3%)
June 2015
-
-$4.23 M(+35.0%)
-$14.14 M(+4.5%)
Mar 2015
-
-$3.13 M(-16.2%)
-$13.53 M(-15.8%)
Dec 2014
-$16.08 M(+7.8%)
-$3.73 M(+22.4%)
-$16.08 M(-4.7%)
Sept 2014
-
-$3.05 M(-15.7%)
-$16.88 M(+3.2%)
June 2014
-
-$3.62 M(-36.3%)
-$16.36 M(-6.4%)
Mar 2014
-
-$5.68 M(+25.2%)
-$17.47 M(+17.2%)
Dec 2013
-$14.91 M(+89.0%)
-$4.53 M(+79.5%)
-$14.91 M(+7.1%)
Sept 2013
-
-$2.53 M(-46.7%)
-$13.92 M(-1.6%)
June 2013
-
-$4.74 M(+52.2%)
-$14.16 M(+33.3%)
Mar 2013
-
-$3.11 M(-12.2%)
-$10.62 M(+21.9%)
Dec 2012
-$7.89 M(>+9900.0%)
-$3.55 M(+28.5%)
-$8.72 M(+68.3%)
Sept 2012
-
-$2.76 M(+129.3%)
-$5.18 M(+113.6%)
June 2012
-
-$1.20 M(-0.2%)
-$2.42 M(+96.8%)
Mar 2012
-
-$1.21 M(>+9900.0%)
-$1.23 M(+3991.7%)
Dec 2011
-
-$8300.00(+59.6%)
-$30.10 K(+11.5%)
Sept 2011
-
-$5200.00(-55.6%)
-$27.00 K(+2.3%)
June 2011
-$26.50 K(+29.3%)
-$11.70 K(+138.8%)
-$26.40 K(+18.4%)
Mar 2011
-
-$4900.00(-5.8%)
-$22.30 K(+0.5%)
Dec 2010
-
-$5200.00(+13.0%)
-$22.20 K(+4.2%)
Sept 2010
-
-$4600.00(-39.5%)
-$21.30 K(+27.5%)
June 2010
-
-$7600.00(+58.3%)
-$16.70 K(+83.5%)
June 2010
-$20.50 K
-
-
Mar 2010
-
-$4800.00(+11.6%)
-$9100.00(+111.6%)
Dec 2009
-
-$4300.00
-$4300.00

FAQ

  • What is ADMA Biologics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for ADMA Biologics?
  • What is ADMA Biologics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for ADMA Biologics?
  • What is ADMA Biologics quarterly EBIT year-on-year change?
  • What is ADMA Biologics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for ADMA Biologics?
  • What is ADMA Biologics TTM EBIT year-on-year change?

What is ADMA Biologics annual earnings before interest & taxes?

The current annual EBIT of ADMA is -$3.21 M

What is the all time high annual EBIT for ADMA Biologics?

ADMA Biologics all-time high annual earnings before interest & taxes is $5.12 M

What is ADMA Biologics quarterly earnings before interest & taxes?

The current quarterly EBIT of ADMA is $40.25 M

What is the all time high quarterly EBIT for ADMA Biologics?

ADMA Biologics all-time high quarterly earnings before interest & taxes is $40.25 M

What is ADMA Biologics quarterly EBIT year-on-year change?

Over the past year, ADMA quarterly earnings before interest & taxes has changed by +$51.68 M (+452.13%)

What is ADMA Biologics TTM earnings before interest & taxes?

The current TTM EBIT of ADMA is $90.62 M

What is the all time high TTM EBIT for ADMA Biologics?

ADMA Biologics all-time high TTM earnings before interest & taxes is $90.62 M

What is ADMA Biologics TTM EBIT year-on-year change?

Over the past year, ADMA TTM earnings before interest & taxes has changed by +$93.83 M (+2920.48%)